UPLOAD Filing
Spring Valley Acquisition Corp. III
Date: Aug. 13, 2025 · CIK: 0002074850 · Accession: 0000000000-25-008495
AI Filing Summary & Sentiment
File numbers found in text: 333-289294
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Christopher Sorrells Chief Executive Officer Spring Valley Acquisition Corp. III 2100 McKinney Ave., Suite 1675 Dallas, TX 75201 Re: Spring Valley Acquisition Corp. III Registration Statement on Form S-1 Filed August 6, 2025 File No. 333-289294 Dear Christopher Sorrells: We have reviewed your registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Registration Statement on Form S-1 Proposed Business Sponsor Information, page 13 1. We note your response to prior comment 7. Please state the current amount of interest Christopher Sorrells has in the sponsor. See Item 1603(a)(7) of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. August 13, 2025 Page 2 Please contact Christine Torney at 202-551-3652 or Daniel Gordon at 202-551-3486 if you have questions regarding comments on the financial statements and related matters. Please contact Doris Stacey Gama at 202-551-3188 or Chris Edwards at 202-551- 6761 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jason Simon, Esq. </TEXT> </DOCUMENT>